Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow
2026-06-03
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables specific, sensitive detection of goat IgG in fluorescence-based assays such as ICC/IF, IHC, flow cytometry, and ELISA. It is not designed for non-goat primary antibodies or unsupported assay types. Proper handling and adherence to validated protocols are essential for consistent results.
-
RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3
2026-06-03
Wu et al. demonstrate that Reticulocalbin 2 (RCN2) promotes metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) through UBR5-mediated degradation of PPP2CA, leading to activation of the PI3K-Akt signaling pathway. Their mechanistic findings offer a compelling rationale for targeting the RCN2-PPP2CA-PI3K-Akt axis to overcome aggressive disease and chemoresistance in ESCC.
-
SU6656 Src Tyrosine Kinases Inhibitor: Applied Protocols & O
2026-06-02
SU6656, a potent Src tyrosine kinases inhibitor, is driving breakthroughs in both radiotherapy sensitization and scalable platelet production from hiPSCs. This article unpacks stepwise experimental workflows, key innovations, and troubleshooting strategies to maximize SU6656's translational value for cancer and regenerative medicine researchers.
-
Demethyleneberberine: Applied Workflows in Cell and Animal M
2026-06-02
Demethyleneberberine (DMB) delivers multi-pathway inhibition and robust reproducibility in cell culture and animal disease models, making it a versatile anti-inflammatory and neuroprotective agent. This article highlights advanced experimental setups, troubleshooting strategies, and evidence-backed protocol optimizations, providing researchers actionable guidance for maximizing DMB’s impact in translational studies.
-
Ceramide-Driven Lipid Remodeling in Fish Nodavirus Infection
2026-06-01
The reference study demonstrates that ceramide accumulation, driven by both viral infection and capsid protein expression, is a key pro-viral mechanism in red-spotted grouper nervous necrosis virus (RGNNV) pathogenesis. Lipidomics revealed that ceramides promote viral replication largely through autophagy induction, suggesting new intervention points for fish virology and cell biology research.
-
iPSC-Derived Multilineage Organoids Model Pan-Tissue HEV Inf
2026-06-01
This study establishes induced pluripotent stem cell (iPSC)-derived liver, intestinal, and brain organoids as robust models for pan-genotype hepatitis E virus (HEV) infection. By capturing the full HEV life cycle and revealing tissue-specific pathogenic mechanisms, these organoids offer a powerful platform for virology research and antiviral drug development, surpassing traditional cell culture limitations.
-
Phosbind Biotin: Transforming Phosphorylation Analysis in Dr
2026-05-31
Explore how APExBIO’s Phos binding reagent (Phosbind) Biotin leverages dinuclear metal complex phosphate binding to elevate Western Blot detection of phosphorylated proteins, enabling translational researchers to decode plant stress responses—especially phosphorylation-driven mechanisms in drought tolerance. This thought-leadership article integrates mechanistic insight, workflow strategy, and actionable protocol guidance, building upon recent advances in Populus trichocarpa drought studies and expanding the conversation beyond typical product pages.
-
Spatially Concentrated Base Editors Correct PLP1 Mutations i
2026-05-30
This study introduces a spatially concentrated adenine base editing (cABE) strategy that selectively enhances correction of PLP1 mutations in oligodendrocytes, addressing inefficient gene editing in these challenging cell types. The approach demonstrates improved on-target editing and reduced off-target effects, offering a technical framework for gene therapy in myelin disorders.
-
Estradiol, ER-α, and ER Stress: Restoring CD4+ T Cells Post-
2026-05-29
This study demonstrates that 17β-estradiol, acting through ER-α and GPR30, suppresses endoplasmic reticulum stress (ERS) to normalize the proliferation and cytokine production of splenic CD4+ T lymphocytes after hemorrhagic shock. The findings clarify distinct estrogen receptor pathways in immune recovery, offering new mechanistic insight for immunomodulation after trauma.
-
CBD Modulates FAAH and Endocannabinoid Pathways in Orofacial
2026-05-29
This study reveals cannabidiol’s (CBD) capacity to alleviate both sensory and emotional aspects of orofacial inflammatory pain through multi-level modulation of FAAH and endocannabinoid signaling. These findings point to the translational promise of targeting enzymatic and receptor pathways for comprehensive pain management.
-
Isradipine (Dynacirc): Applied Strategies for Vascular & Neu
2026-05-28
Isradipine (Dynacirc) stands out as a high-purity, selective L-type calcium channel blocker, empowering precise experimental modulation in both vascular smooth muscle and neurodegenerative models. This article bridges cutting-edge mechanistic insights with actionable workflows, troubleshooting, and comparative context—enabling researchers to maximize the translational value of APExBIO’s Isradipine in hypertension and neuroprotection studies.
-
L-NAME Hydrochloride (A7088): Reliable NOS Inhibition in Lab
2026-05-28
This article delivers scenario-driven, evidence-based guidance for biomedical researchers and lab technicians leveraging L-NAME Hydrochloride (SKU A7088) for precise NOS inhibition in cell viability and cytotoxicity assays. Explore validated best practices, protocol parameters, and vendor selection advice grounded in quantitative data and peer-reviewed insights.
-
D-Luciferin Potassium Salt: Redefining Bioluminescence for T
2026-05-27
This thought-leadership article explores how D-Luciferin (potassium salt) is advancing in vivo bioluminescence imaging and luciferase reporter assays, providing mechanistic clarity, strategic guidance, and translational value for researchers designing next-generation disease models and therapeutic studies.
-
V5 Epitope Tag Peptide: Precision for Protein Detection & Ta
2026-05-27
The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) enables highly reproducible, high-affinity protein detection, purification, and advanced imaging across molecular biology workflows. This article delivers actionable guidance for integrating the V5 tag into Western blot, immunoprecipitation, and super-resolution microscopy, highlighting recent innovations in antibody screening and troubleshooting.
-
Sulfo-NHS-SS-Biotin: Practical Guide for Cleavable Labeling
2026-05-26
Sulfo-NHS-SS-Biotin is a water-soluble, amine-reactive biotin disulfide N-hydroxysulfosuccinimide ester for selective, reversible protein labeling, particularly at the cell surface. It is best suited for workflows requiring membrane-impermeant labeling and downstream affinity purification, but is not appropriate for intracellular targets or protocols needing long-term reagent stability.